Eisai
4523.T
#2141
Rank
HK$70.66 B
Marketcap
HK$250.36
Share price
3.89%
Change (1 day)
12.76%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): HK$17.10

According to Eisai's latest financial reports the company's current EPS (TTM) is HK$6.79. In 2022 the company made an earnings per share (EPS) of HK$12.57 a decrease over its 2021 EPS that were of HK$55.79.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$17.1036.05%
2022HK$12.57-77.48%
2021HK$55.79-41.88%
2020HK$95.99-0.94%
2019HK$96.9052.59%
2018HK$63.50124.17%
2017HK$28.33-49.42%
2016HK$56.0137.08%
2015HK$40.86-11.75%
2014HK$46.30-3.23%
2013HK$47.84-18.56%
2012HK$58.75-15.51%
2011HK$69.54-3.75%
2010HK$72.25-1.36%
2009HK$73.25